You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HER2-targeted therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-positive Breast Cancer Trial (Standard of Care Adjuvant Breast Radiation, Standard of Care HER2-targeted Therapy Without

Not yet recruiting
  • HER2-positive Breast Cancer
  • Standard of Care Adjuvant Breast Radiation
  • Standard of Care HER2-targeted Therapy Without Adjuvant Breast Radiation
  • (no location specified)
Jan 20, 2023

Cardiotoxicity, HER2-positive Breast Cancer, Heart Failure Trial in London (Phased withdrawal of heart failure medications)

Not yet recruiting
  • Cardiotoxicity
  • +3 more
  • Phased withdrawal of heart failure medications
  • London, United Kingdom
  • +1 more
May 19, 2023

Breast Cancer Trial in Ottawa (Trastuzumab)

Recruiting
  • Breast Cancer
  • Ottawa, Ontario, Canada
    The Ottawa Hospital Cancer Centre
Apr 26, 2022

Breast Cancer Trial in Birmingham ([89Zr]-Df-Trastuzumab, PET/MRI Imaging)

Recruiting
  • Breast Cancer
  • Birmingham, Alabama
    The Kirklin Clinic
Feb 1, 2022

Gastric Cancer and Establishment and Verification of Monitoring

Not yet recruiting
  • HER2 Positive Gastric Cancer
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Dec 14, 2021

    HER2-positive Breast Cancer Trial (Thero2-01S22, Placebo)

    Not yet recruiting
    • HER2-positive Breast Cancer
    • (no location specified)
    Jan 13, 2023

    Breast Cancer Metastases, HER2 Positive Breast Trial in New York (89Zr-trastuzumab, PET/CT scan, 89Zr-pertuzumab)

    Completed
    Has Results
    • Breast Cancer Metastases
    • HER2 Positive Breast
    • 89Zr-trastuzumab
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 25, 2021

    Molecular Imaging in HER2-positive Breast Cancer During

    Enrolling by invitation
    • HER2-positive Breast Cancer
    • Female
    • Tomsk, Russian Federation
    • +1 more
    Jun 7, 2022

    Metastatic Breast Cancer Trial in Shanghai (Trastuzumab, pyrotinib, Dalpiciclib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center Shanghai, China, 200032
    Oct 11, 2022

    Cardiac Toxicity, Early-stage Breast Cancer Trial in United States (Lipitor 40mg Tablet)

    Suspended
    • Cardiac Toxicity
    • Early-stage Breast Cancer
    • Lipitor 40mg Tablet
    • Elizabeth, New Jersey
    • +9 more
    Oct 4, 2022

    Breast Cancer Female Trial in Tomsk ([99mTc]Tc-G3-(G3S)3C)

    Enrolling by invitation
    • Breast Cancer Female
    • Tomsk, Russian Federation
      Olga
    Jun 19, 2023

    HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

    Recruiting
    • HR+/HER2- Advanced Breast Cancer
    • Targeted Therapy
    • Beijing, Beijing, China
      National Cancer Center/National Clinical Research Center for Can
    Aug 1, 2023

    Breast Cancer Trial (consilium care™ app)

    Not yet recruiting
    • Breast Cancer
    • consilium care™ app
    • (no location specified)
    Jun 16, 2022

    99mTc-DARPinG3 SPECT/CT for Non-invasive HER2-AX in Breast

    Enrolling by invitation
    • Breast Cancer Female
    • 99mTc-DARPinG3 SPECT/CT
    • Tomsk, Russian Federation
      Russia Tomsk NRMC
    Jan 23, 2023

    Malignant Tumor, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Duarte

    Recruiting
    • Malignant Neoplasm
    • +4 more
    • Chimeric Antigen Receptor T-Cell Therapy
    • Duarte, California
      City of Hope Medical Center
    Sep 14, 2022

    HER-2 Gene Amplification, HER2-positive Gastric Cancer, HER2-positive Breast Cancer Trial in United States (chimeric antigen

    Recruiting
    • HER-2 Gene Amplification
    • +4 more
    • chimeric antigen receptor (CAR) T cell therapy
    • Duarte, California
    • +6 more
    Aug 10, 2022

    Breast Cancer Female Trial in Tomsk (99mTc-ADAPT6, 99mTc-DARPinG3)

    Recruiting
    • Breast Cancer Female
    • Tomsk, Russian Federation
      Tomsk NRMC
    May 12, 2022

    HER2+ Breast Cancer Trial in Xi'an (Trastuzumab, Pertuzumab, Nab paclitaxel)

    Recruiting
    • HER2+ Breast Cancer
    • Xi'an, Shaanxi, China
    • +1 more
    Jun 20, 2022

    HER2-positive Breast Cancer Trial in Birmingham ([18F]-FDG)

    Recruiting
    • HER2-positive Breast Cancer
    • Birmingham, Alabama
      The University of Alabama at Birmingham
    Jan 31, 2022

    Breast Cancer, Adjuvant Therapy Trial in Fuzhou (Pyrotinib+Trastuzumab+Capecitabine, Trastuzumab+Pertuzumab/Trastuzumab)

    Recruiting
    • Breast Cancer
    • Adjuvant Therapy
    • Fuzhou, Fujian, China
      Fujian Medical University Union Hospital
    Mar 14, 2022

    HER-2 Positive Breast Cancer Patients at High Altitude

    Not yet recruiting
    • HER2-positive Breast Cancer
    • +3 more
    • High altitude
    • Xining, Qinghai, China
      Affiliated Hospital of Qinghai University
    Sep 30, 2021

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

    Recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +19 more
    • pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 1, 2022

    HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer Trial in Canada (Endocrine therapy may include one of the following

    Active, not recruiting
    • HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
    • Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant
    • Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapy
    • Calgary, Alberta, Canada
    • +24 more
    Sep 12, 2022

    HER2 Positive Advanced Solid Tumors Trial (HypoSti.CAR-HER2 T cells, Albumin-bound paclitaxel, Cyclophosphamide)

    Not yet recruiting
    • HER2 Positive Advanced Solid Tumors
    • HypoSti.CAR-HER2 T cells
    • +2 more
    • (no location specified)
    Jan 12, 2023

    Oligometastatic Breast Carcinoma, Breast Cancer, Metastatic Breast Cancer Trial in United States (Stereotactic body

    Recruiting
    • Oligometastatic Breast Carcinoma
    • +5 more
    • Stereotactic body radiotherapy
    • Basking Ridge, New Jersey
    • +6 more
    Sep 6, 2022